Congenital Central Hypoventilation Syndrome (CCHS) is a rare genetic disorder that affects the automatic control of breathing. Individuals with CCHS typically have difficulty sensing low oxygen and high carbon dioxide levels, particularly during sleep. This can lead to shallow or inadequate breathing, especially when they are asleep, which may result in serious health complications if not managed properly. CCHS is often diagnosed in infancy or early childhood and is usually caused by mutations in the PHOX2B gene. Treatment typically involves monitoring breathing patterns and may require the use of a ventilator during sleep to ensure adequate oxygen levels. Early intervention is crucial for managing the condition effectively.